256
Participants
Start Date
September 30, 2011
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
Vaccination with FAB-3511
One 0.5 mL injection of FAB-3511 trivalent influenza vaccine containing 3.5μgHA of seasonal A/H1N1, A/H3N2 and B influenza antigens.
Vaccination with FAB-6011
One 0.5 mL injection of FAB-6011 trivalent influenza vaccine containing 6μgHA of seasonal A/H1N1, A/H3N2 and B influenza antigens.
Vaccination with FAB-9011
One 0.5 mL injection of FAB-9011 trivalent influenza vaccine containing 9μgHA of seasonal A/H1N1, A/H3N2 and B influenza antigens.
Vaccination with FluvalAB
One 0.5 mL injection of FLUVAL AB trivalent influenza vaccine containing 15μgHA of seasonal A/H1N1, A/H3N2 and B influenza antigens.
Family Doctor's Office, Budapest
Family Doctor's Office, Budapest
Family Doctor's Office, Szentendre
Family Doctor's Office, Dunakeszi
Lead Sponsor
Fluart Innovative Vaccine Ltd, Hungary
INDUSTRY